epigallocatechin gallate has been researched along with hymecromone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Bánhegyi, G; Benedetti, A; Csala, M; Gamberucci, A; Konta, L; Magyar, JE; Mandl, J; Margittai, E | 1 |
2 other study(ies) available for epigallocatechin gallate and hymecromone
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Endoplasmic reticulum stress underlying the pro-apoptotic effect of epigallocatechin gallate in mouse hepatoma cells.
Topics: alpha-Glucosidases; Animals; Antineoplastic Agents; Apoptosis; Calcium; Catechin; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Eukaryotic Initiation Factor-2; Fluorescent Antibody Technique; Glucosides; Glycoside Hydrolase Inhibitors; Hymecromone; Liver Neoplasms, Experimental; Mice; Phosphorylation; Protein Folding; Stress, Physiological; Time Factors; Transcription Factor CHOP | 2009 |